ArticleClinical and translational medicine2025

Plasma metabolites in patients of the REDINSCOR III registry hospitalised for de novo heart failure with preserved ejection fraction: Prognostic implications of linoleamide and 2-trans,4-cisdecadienoylcarnitine levels.

Marta Delgado-Arija et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.